The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Envafolimab plus chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study.
 
Jinbo Zhao
No Relationships to Disclose
 
Xiaolong Yan
No Relationships to Disclose
 
Yuquan Bai
No Relationships to Disclose
 
Hongtao Duan
No Relationships to Disclose
 
Tao Jiang
No Relationships to Disclose